Balloon-assisted Enteroscopy and Bacteria

NCT ID: NCT01065324

Last Updated: 2010-02-09

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

200 participants

Study Classification

OBSERVATIONAL

Study Start Date

2010-02-28

Study Completion Date

2012-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

1. Balloon-assisted enteroscopy (BAE) is a new tool to investigate small intestinal diseases.
2. Deep enteroscopy made possible by balloon expansion and manipulation of small intestines.
3. However, whether intestinal barrier injured during BAE predispose patients to bacteremia or clinical relevant infection is not studied.
4. We will also examine relevant patient factors.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The newly developed balloon-assisted enteroscopy systems allow insertion of the enteroscopy deeply into the small intestines by fixation of the soft, redundant small intestines with an inflatable balloon over the tip of the overtube. However, the inflation of balloon might stimulate the intestinal mucosa, and the deep manipulation of intestinal segments might also compromise the intestinal barrier function. According to our preliminary experience of balloon-assisted enteroscopy (which is among the first groups in Taiwan), we experienced a significant case of suspected post-procedural bactermia patient. Besides, there is also a published case report from the UK reporting Streptococcus milleri bacteremia which is suspected as bacterial translocation after balloon-assisted enteroscopy. However, currently there is no original study focusing on the intestinal barrier / permeability defects or bacterial translocation. This is a timely and novel research topic in the current developing era of balloon-assisted enteroscopy.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Enteritis Bleeding

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Anally inserted enteroscopy group

Anally inserted enteroscopy group

No interventions assigned to this group

Orally inserted enteroscopy group

Orally inserted enteroscopy group

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* adult patients with clinical suspicions of small intestinal lesions in need of balloon-assisted enteroscopy examinations
* signed written informed consents

Exclusion Criteria

* Patients with active infection or receiving systemic (oral or intravenous) antibiotics within recent 3 months (this may decrease effect of bacterial translocation) or taking drugs that may affect renal function within 3 months
* Unstable health condition for balloon-assisted enteroscopy (unstable hemodynamics, severe cardiopulmonary compromise)
* Pregnancy
* known allergy to lactulose, mannitol
* Refuse to sign written informed consent of this study.
* patients would be advised to hold prokinetic agents
Minimum Eligible Age

18 Years

Maximum Eligible Age

90 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

National Taiwan University Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

NTUH

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

TC Lee, MD

Role: PRINCIPAL_INVESTIGATOR

NTUH

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

E-Da Hospital

Kaohsiung City, , Taiwan

Site Status RECRUITING

NTUH

Taipei, , Taiwan

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Taiwan

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

TC Lee, MD

Role: CONTACT

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

CM Tai, MD

Role: primary

TC LEE, MD

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

200812154R

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Transgastrostomal Endoscopies
NCT04309825 WITHDRAWN NA